During the past decade, CODA, Inc. conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 8 clinical trials were completed, i.e. on average, 80% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 4 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CODA, Inc." #1 sponsor was "Indivior Inc." with 5 trials, followed by "T. John Winhusen, PhD" with 3 trials sponsored, "University of California, Los Angeles" with 3 trials sponsored, "Medical University of South Carolina" with 1 trials sponsored and "National Institute on Drug Abuse (NIDA)" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CODA, Inc." #1 collaborator was "National Institute on Drug Abuse (NIDA)" with 8 trials as a collaborator, "The Emmes Company, LLC" with 5 trials as a collaborator and "University of California, San Francisco" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "CODA, Inc." are "Opioid-Related Disorders" (4 trials), "Drug Abuse" (3 trials), "Drug Abuse in Pregnancy" (3 trials), "Drug Addiction" (3 trials) and "Neonatal Abstinence Syndrome" (3 trials). Many other conditions were trialed in "CODA, Inc." in a lesser frequency.

Most popular intervention types in "CODA, Inc." are "Drug" (11 trials), "Behavioral" (1 trials), "Diagnostic Test" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Buprenorphine Injection" (3 trials), "Buprenorphine Sublingual Product" (3 trials), "RBP-6000" (3 trials), "Placebo" (2 trials) and "Blood sample collection" (1 trials). Other intervention names were less common.

The vast majority of trials in "CODA, Inc." are 13 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "CODA, Inc.". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in CODA, Inc., undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in CODA, Inc., 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".